Cite
HARVARD Citation
Li, P. et al. (2022). Identification of an AXL kinase inhibitor in triple‐negative breast cancer by structure‐based virtual screening and bioactivity test. Chemical biology & drug design. pp. 222-232. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Li, P. et al. (2022). Identification of an AXL kinase inhibitor in triple‐negative breast cancer by structure‐based virtual screening and bioactivity test. Chemical biology & drug design. pp. 222-232. [Online].